International Biotechnology Trust PLC I Mab Transaction History
International Biotechnology Trust PLC
- $295 Million
- Q3 2023
A detailed history of International Biotechnology Trust PLC transactions in I Mab stock. As of the latest transaction made, International Biotechnology Trust PLC holds 310,499 shares of IMAB stock, worth $316,708. This represents 0.14% of its overall portfolio holdings.
Number of Shares
310,499
Previous 310,499
-0.0%
Holding current value
$316,708
Previous $928,000
55.93%
% of portfolio
0.14%
Previous 0.29%
Shares
6 transactions
Others Institutions Holding IMAB
# of Institutions
37Shares Held
16MCall Options Held
56.4KPut Options Held
5.8K-
Hhlr Advisors, Ltd. Grand Cayman, E96.91MShares$7.05 Million0.2% of portfolio
-
Decheng Capital Management Iii (Cayman), LLC4.17MShares$4.25 Million3.04% of portfolio
-
Boothbay Fund Management, LLC New York, NY1.42MShares$1.45 Million0.05% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U0567KShares$577,9830.0% of portfolio
-
David A. Siegel Two Sigma Advisers, LP | New York, Ny499KShares$509,2860.0% of portfolio
About I-Mab
- Ticker IMAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 83,098,800
- Market Cap $84.8M
- Description
- I-Mab, a clinical stage biopharmaceutical company, discovers, develops, and commercializes biologics to treat cancer and autoimmune disorders. It is developing Felzartamab, a CD38 antibody that is in Phase 1b/2a for patients with membranous nephropathy; Eftansomatropin alfa, a long-acting human growth hormone, which has completed Phase 3 clinica...